BRUIN CLL-313 showed significantly longer progression-free survival vs bendamustine plus rituximab, bringing a noncovalent BTK inhibitor to first-line care.
|Articles|April 1, 2006
- Volume 0 0
Scranton, Pa, Tops Asthma Capitals
Advertisement
The Asthma and Allergy Foundation of America (AAFA) recently released its third annual US Asthma Capitals rankings. The order is based on 12 factors from 3 broad categories?prevalence, risk, and medical factors?for all 100 metropolitan areas. This year, AAFA is calling attention to allergic asthma. Research conducted by the organization indicated that nearly half of all asthma patients do not have their asthma under "control," and awareness about allergic asthma is low. The complete list is available at www.AsthmaCapitals.com. The top 10 Asthma Capitals are:
- Scranton, Pa
- Richmond, Va
- Philadelphia, Pa
- Atlanta, Ga
- Milwaukee, Wis
- Cleveland, Ohio
- Greensboro, NC
- Youngstown, Ohio
- St. Louis, Mo
- Detroit, Mich
Articles in this issue
over 20 years ago
Should Pharmacists Receive Overtime Pay?over 20 years ago
Pharmacists—Cops or Not? (Part 2)over 20 years ago
canyouREADtheseRxs?over 20 years ago
compoundingHOTLINEover 20 years ago
NSAIDs and Antihypertensive Agentsover 20 years ago
FDA Approves New Constipation Drugover 20 years ago
Angina Drug Approvedover 20 years ago
Pancreatic Cancer Trials Offer Positive Resultsover 20 years ago
Cancer Drug Receives Approval for 2 Conditionsover 20 years ago
Long-term LNG/EE Use Does Not Hinder Future OvulationAdvertisement
Related to this article
A behavioral walking program matched supervised aerobic training for improving asthma control in a randomized trial of physically inactive adults.
Phase 2b data from EASD 2026 show the amylin-incretin combination also cut HbA1c by up to 2.9% in adults with obesity or overweight and type 2 diabetes.
American Pharmacists Month kicked off on October 1, honoring more than 700,000 pharmacy professionals and 250 years of caring for America's communities.
fMRI data show cagrilintide-semaglutide altered brain responses to high-calorie food cues; REIMAGINE analyses point to ectopic fat and bone effects.
Decades after cisplatin's approval, platinum-based chemotherapy continues to anchor treatment regimens across tumor types, new research finds.
A pharmacist-led collaborative drug therapy management program at NYC Health + Hospitals/Bellevue reported high patient satisfaction, and every surveyed patient said they felt respected and supported by their pharmacist.
A Novo Nordisk–funded claims analysis of adults with type 2 diabetes found an adjusted HR of 1.06 for MACE with switching, although the findings cannot show causation.
Advertisement
Advertisement
Trending on Pharmacy Times
1
EloraTZP Delivers Up to 23.3% Weight Loss in Adults With Obesity and T2D
2
Pharmacists Key to Lp(a) Counseling and Lipid Optimization
3
Why Lp(a) Testing Lagged Behind LDL Cholesterol Screening
4
What the 2025-2030 Dietary Guidelines Mean for Heart Health
5